Objectives: The identification of antimicrobial resistance of isolates present in pediatric cardiac intensive care unit (PCICU) is important to prevent further spread, because this department limited choice of antibiotic. The aim of the present study is to report the antibiotic resistance rate of most frequently pathogens in PCICU during a five-year period.
INTRODUCTION
Pneumonia, septicemia and postoperative wound are most frequent types of infections in patients requiring intensive care treatment. Postoperative infections are important and main cause for the increasing morbidity, such as the widespread use of antibiotics, reoperations, prolonged stay in intensive care unit (ICU), and all of this increases cost of treatment and the use of resources [1] . Moreover, postoperative infections are a major factor for increasing mortality [2] [3] [4] [5] .
Postoperative surgical site infections are a major cause of postoperative morbidity and mortality in cardiac surgery. While surgical site infection in adult cardiac surgery has been well characterized and studied, in pediatric cardiac surgery, the classification, prevention and management is less well studied and significant practice variation exist [6] [7] [8] .
As is known, children have a relatively underdeveloped immune system, because of this is at high risk for nosocomial infection, especially when they need prolonged hospital stay, major surgery, or invasive procedures [9] [10] [11] .
In pediatric cardiac surgery bacterial infections are basic cause of morbidity and mortality [12] . Pediatric patients are more susceptible for infection than adult particularly in the first two years of life. The identification of antimicrobial resistance of isolates present in pediatric cardiac intensive care unit (PCICU) is important to prevent further spread, because this department [13] .
All these findings support the need of strict adherence to monitoring antibiotic resistance of strains in pediatric intensive care unit (PICU), together with the control measures to prevent the spread of multi-drug resistant microorganism. The objective of the present study is to report the antibiotic resistance rate of most frequently pathogens in PCICU during a five-year period, from 2012 to 2016.
METHODS

Study design
A prospective study of microbial landscape and antibiotic resistance rates of strains from patients in PCICU was conducted, during the study period 2012-2016.
Data collection
Data were collected from newborns and children of the first three years hospitalized in pediatric cardiac ICU after cardiac surgery (surgery on the heart and major blood vessels). All patients in the PCICU were monitored for bacterial infection at body sites for a period at least one month. Strains were analyzed by infection site and pathogen type.
Bloodstream strains were collected from patient with either two or more positive blood cultures. Respiratory tract specimens included nasopharyngeal swabs and sputum. Other types of specimens obtained from the patients were: swabs from cardiac surgical wounds, Bronchoalveolar lavage, central venous catheter (CVC), aspiration catheter, tracheostomy, pleural cavity, peritoneal fluid. All specimens were collected at the bed site, transported to the Laboratory of Microbiology and were inoculated on proper culture media within two hours according to the guidelines [14] .
Samples cultivation
Clinical specimens were inoculated onto 5% sheep blood agar, Mannitol salt agar, Endo agar, Sabouraund dextrose agar (Himedia, India). Plates were incubated at 37°C for 18-24 hours.
Identification of isolates
Methods used for confirmation of identification included test of colonial morphology, haemolytic activity on appropriate agar media, Gram strain, rapid tests (coagulase, oxidase, catalase, indole) and use of automated identification system Vitek 2-Compact (bioMerieux, Marcy I'Etoile, France).
Antibiotic susceptibility testing
The following antibiotics were used for antimicrobial susceptibility testing: ticarcillin/clavulanic acid, amoxicillin/clavulanic acid, ceftazidime, ceftriaxone, cefepime, amikacin, meropenem, gentamicin, ciprofloxacin, levofloxacin. Susceptibility tests were performed with broth microdilution method (Vitek 2 -Compact (bioMerieux, Marcy I'Etoile, France) according to the manufacturer's guideline recommendations. Colonies from 18-24 hours culture were used to inoculate the microdilution cards.
All data were analyzed using Microsoft Access and Excel. Trends over time of antibiotic resistance rates were determined by linear regression with the yearly data. A p value of <0.05 was considered to be statistically significant. K. pneumoniae isolates showed tendency of increasing resistance to 3rd generation cephalosporins (ceftriaxone from 38.4% to 85.7% and carbapenems (meropenem from 0% to 7.1%) ( Table 4 ).
RESULTS
During study period from
The greatest percentage of Candida spp. strains were isolated from BSI and resistance rate to antibiotics was to amphotericin B 22.2% (95%Cl 3.9-59.8), to fluconazole 100% (95%Cl 62.9-100), to intraconazole 88.9% (95%Cl 50.7-99.4), to ketoconazole 11.1% (95%Cl 0.6-49.3). 
DISCUSSION
According to systems involved infection in PICU our study results showed the most common systems affected were respiratory tract and bloodstream. In most of other studies are the commonest infection affected by respiratory tract followed urinary tract infection [15] [16] .
Organisms that affect PICU in general, were variable among hospitals. In same researches, CNS is the most common pathogens in PICU, followed by K. pneumoniae, P. aeruginosa and S. aureus [17] [18] . Bo-Tao Ning et al. reported that the most common pathogens were Acinetobacter baumannii (25.6%), Escherichia coli (20.2%), S. maltophilia (20.2%), K. pneumoniae (16.2%) and P. aeruginosa (9.4%) [19] . Our study showed K. pneumoniae the commonest, followed by P. aeruginosa then Candida spp. Furthermore, during study period there is tendency of increasing percentage of P. aeruginosa from 2.6% to 10.8% (p=0.018), K. pneumoniae from 2.6% to 10.5% (p=0.023), Candida spp. from 1.6% to 5.9% (p=0.033).
Studies of surveillance of nosocomial infections may help to decrease the frequency incidence of infections and reducing long ICU stays and hence the costs. Infections with Candida spp. are one of the most leading causes of nosocomial bloodstream infections [20] . PICU patients with candidemia are at highest risk of death [21] . In same studies (Becerra M R, 2010) the most common isolate in BSI in pediatric patients was Candida spp. (41%), followed CNS. In same studies (Singhi S et.al 2008) candidemia developed in 30.2% cases [6, 7] .
Risk factors for candidemia are previous colonization, long ICU stays, presence of CVC, parenteral nutrition, illness severity and prolonged use of antibiotics [22] . Candidemia is particularly important, because it is associated with high mortality, both in adults [23] and children, especially at lower ages and in those with comorbidities [24] .
The same authors in the study of BSI in PICU identified that the most frequent pathogens were CNS (24%), K. pneumoniae (16%), Candida spp. (15%), P. aeruginosa (7%) and S. aureus (6%) [17] .
Our findings are consistent with results of other authors [25] [26] . In our study BSI was increased from 7.5% to 18.2% (p<0.05), the most frequent pathogens were K. pneumoniae (29.4%) and Candida spp. (18.9%). It is likely that the most important cause of our high prevalence of Candida spp. is the extensive use of broad spectrum antibiotics. Furthermore, in our study resistance rates of Candida spp. isolates to amphotericin B was 22.2% (95%Cl 3.9-59.8), to fluconazole 100% (95%Cl 52.9-100).
The tracheobronchial tree and oropharynx of patients on mechanical ventilation are frequently contaminated by microorganisms [27] . The relation between this colonization and pulmonary infection, however, is not yet clear. Johanson et al. [28] showed that 23% of patients colonized by bacteria later developed pulmonary infection. Gram-negatives, mainly P. aeruginosa the most common organism in tracheobronchial tree [29] , as in our study, and with K.pneumoniae, both caused 35.9% of infection.
Clinical studies report increasing resistance rates of P. aeruginosa in PICU, which is a factor of nosocomial infection [30] [31] . Wang LG. et al. reported that out of 126 P. aeruginosa isolates more than 50% were resistance to capbaphenems, 33.3% to ceftazidime [32] . In our study, examining the five-year average antimicrobial resistance distributions of P. aeruginosa strains, the highest resistance observed for carbapenems, aminoglycosides and antipseudomonal cephalosporins. In particular, resistance to meropenem dramatically increased from 8.3% to 83.1% (p=0.004), to ceftazidime from 8.3% to 66.7% (p=0.018), and to gentamicin from 7.7% to 69.5% (p=0.007). K. pneumoniae isolates showed tendency of increasing resistance to 3 rd generation cephalosporins and carbapenems (to ceftriaxone from 38.4% in 2012 to 85.7% in 2016 p=0.033, to ceftazidime from 41.1% to 87.5% p=0.022, to meropenem from 0% to 7.1% p=0.045 respectively.
As is known, developing drug resistance can severely limit the therapeutic options for treatment of serious infections. In our opinion, there are possible reasons for the high rate of resistant isolates in our hospital include more critically ill patients which admitted to the new PICU; more patients being referred from local hospitals; and the spread of resistant strains from adult wards. However, further evaluation of the reasons for the high rate of resistance of P. aeruginosa in the PICU is warranted. We should improve testing technique, early and appropriate empirical antibiotics therapy is crucial according to clinical experience and antibiotic sensitivity. The effective treatment of frequently isolates in ICU is paramount to prevent multidrug resistance.
In conclusion, the present study reported that most frequent isolates in our PCICU were P. aeruginosa and K. pneumoniae. Reporting of dramatically increasing resistance rates of these isolates necessitates a well-designed hospital infection control strategy, including good hygiene, microbiological monitoring, and nosocomial control; all of this will greatly reduce the risk of nosocomial infection.
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